References

  1. Habibi A, Arlet JB, Stankovic K, Gellen-Dautremera J et al. Recommandations françaises de prise en charge de la drépanocytose de l'adulte: actualisation 2015. Rev Med Interne. 2015 May;36(5 Suppl 1):5S3-84. Google Scholar

  2. Godeau B. La drépanocytose chez l'adulte: quelles urgences pour l'interniste. Rev Med Interne. 2000 Dec;21(Suppl 4):436-8. Google Scholar

  3. Ephraim RK, Osakunor DN, Cudjoe O, Oduro EA et al. Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana. BMC Nephrology. 2015 May;16:75. PubMed | Google Scholar

  4. Colella MP V de, Paula U, Machado-Neto JA, Conran N et al. Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica. 2015 Jan; 100(4):466-471. Google Scholar

  5. Napon C, Kaboré A, Ouédraogo M, Dravé A et al. Accidents vasculaires cérébraux et hémoglobinopathies au Burkina Faso. Med Sante Trop. 2012 Oct-Nov-Dec; 22(4):390-393. Google Scholar

  6. Ngo Sack F, Seck M, Faye B, Diop S. Morbidité et aspects évolutifs de la drépanocytose SC: une étude de 129 patients au Service d'Hématologie Clinique de Dakar. Health Sci Dis. 2016 Oct-Nov-Dec; 17(4):57-62. Google Scholar

  7. Latoundji S, Anani L, Ablet E, Zohoun I. Morbidité et mortalité drépanocytaire au Bénin. Med Afr Noire. 1991 Apr;38(8-9):569-71. In press

  8. Perignon A, Botterel F, Farrugia C, Foulet F et al. Paludisme et drépanocytose homozygote. Med Mal Infect. 2008 Jan;38(Suppl 2):S140-S141. In press

  9. Mbika Cardorelle A, Okoko A, Mouko A. Les crises vaso-occlusives de l'enfant drépanocytaire à Brazzaville. Arch Pediatr. 2010 Mar;17(3):294-302.

  10. Gbadoé AD, Atakouma DY, Akoli A, Assimadi JK. Traitement à domicile de la crise vaso-occlusive drépanocytaire au Togo. Arch Pediatr. 1999 Jun;6(9):958-61.

  11. Brousseau DC, Owens PL, Mosso AL, Panepinto JA et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010 Apr;303(13):1288-94. PubMed | Google Scholar

  12. Lanzkron S, Carroll CP, Haywood CJr. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol. 2010 Oct;85(10):797-9. PubMed | Google Scholar

  13. Platt OS, Thorington BD, Brambilla DJ, Milner PF et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 1991 Jul;325(1):11-6. PubMed | Google Scholar

  14. Lionnet F, Arlet JB, Bartolucci P, Habibi A et al. Recommandations pratiques de prise en charge de la drépanocytose de l'adulte. Rev Med interne. 2009 Aug;30(Suppl 3):162-223. Google Scholar

  15. Anie KA. Psychological complications in sickle cell disease. Br J Haematol. 2005 Jun; 129(6):723-9. PubMed | Google Scholar

  16. Platt OS, Brambilla DJ, Rosse WF, Milner PF et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994 Jun; 330(23):1639-44. PubMed | Google Scholar

  17. Vichinsky EP, Neumayr LD, Earles AN, Williams R et al. Causes and outcomes of the acute chest syndrome in sickle cell disease: national Acute Chest Syndrome Study Group. N Engl J Med. 2000 Jun;342(25):1855-65. PubMed | Google Scholar

  18. Bartolucci P, Habibi A, Khellaf M, Roudo-Thoraval F et al. Score prédictif de survenue d'un syndrome thoracique durant une crise vaso-occlusive drépanocytaire dès l'arrivée aux urgences. Rev Med Interne. 2014 Feb;35(2):39-40. Google Scholar

  19. Ferster A, Kentos A, Bradstreet C, Vertongen F et al. Traitement de la crise douloureuse vaso-occlusive. Jeur. 2005 Dec;18(4):234-237. Google Scholar